This review focuses on COPD and identification of high-risk patients, international guidelines on managing exacerbations, pneumonia in COPD and choice of treatments.
The review includes guiding commentary from Professor David Price, Founder and Head of the Observational and Pragmatic Research Institute in Singapore.
Please login below to download this issue (PDF)